Martin Auster
Stock Analyst at Raymond James
(4.56)
# 969
Out of 4,516 analysts
205
Total ratings
51.6%
Success rate
16.1%
Average return
Main Sectors:
Stocks Rated by Martin Auster
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALNY Alnylam Pharmaceuticals | Reiterated: Buy | $377 → $468 | $279.14 | +67.66% | 4 | Jul 9, 2026 | |
| IBIO iBio, Inc. | Initiated Coverage: Buy | $5 | $1.43 | +249.65% | 1 | Jun 8, 2026 | |
| SEPN Septerna | Maintained: Buy | $38 → $53 | $34.07 | +55.56% | 2 | Jun 8, 2026 | |
| EWTX Edgewise Therapeutics | Reiterated: Buy | $46 → $66 | $40.83 | +61.65% | 4 | Jun 1, 2026 | |
| EQ Equillium | Maintained: Buy | $6 → $7 | $2.62 | +167.18% | 2 | May 28, 2026 | |
| TECX Tectonic Therapeutic | Maintained: Buy | $76 → $81 | $32.50 | +149.23% | 2 | May 26, 2026 | |
| BBIO BridgeBio Pharma | Downgraded: Hold | n/a | $82.66 | - | 4 | May 26, 2026 | |
| SYRE Spyre Therapeutics | Initiated Coverage: Buy | $80 | $102.07 | -21.62% | 1 | Apr 10, 2026 | |
| SRRK Scholar Rock Holding | Reiterated: Buy | $53 → $60 | $54.04 | +11.03% | 5 | Mar 30, 2026 | |
| MAZE Maze Therapeutics | Reiterated: Buy | $48 → $56 | $29.39 | +90.54% | 2 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $12.45 | +221.29% | 2 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $26 | $5.91 | +339.93% | 4 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $108 → $117 | $76.02 | +53.91% | 4 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $11.05 | +153.39% | 1 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $271 | $268.57 | +0.90% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $35 | $23.99 | +45.89% | 3 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $82.62 | - | 1 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 → $6 | $45.44 | n/a | 3 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $102 → $100 | $58.95 | n/a | 14 | Oct 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $3.56 | n/a | 1 | Mar 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $8 | $9.62 | n/a | 4 | Mar 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 → $12 | $30.95 | n/a | 2 | Mar 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $49 → $58 | $29.91 | n/a | 6 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $156 → $72 | $17.61 | n/a | 23 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $169 → $196 | $531.79 | n/a | 17 | Feb 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 → $98 | $2.03 | n/a | 5 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $64 → $99 | $31.71 | n/a | 15 | Jan 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $60 | $109.81 | n/a | 17 | Jan 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $53 → $54 | $78.84 | n/a | 12 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $76 → $78 | $41.00 | n/a | 5 | Nov 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 → $12 | $4.00 | n/a | 9 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $24 | $13.04 | n/a | 4 | Nov 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 → $43 | $11.33 | n/a | 4 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $529.00 | n/a | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $14 | $18.58 | n/a | 4 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $3.71 | n/a | 4 | Aug 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 | $55.82 | n/a | 8 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $16 → $4 | $0.0001 | n/a | 3 | Nov 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $0.746 | n/a | 1 | Jan 18, 2018 |
Alnylam Pharmaceuticals
Jul 9, 2026
Reiterated: Buy
Price Target: $377 → $468
Current: $279.14
Upside: +67.66%
iBio, Inc.
Jun 8, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $1.43
Upside: +249.65%
Septerna
Jun 8, 2026
Maintained: Buy
Price Target: $38 → $53
Current: $34.07
Upside: +55.56%
Edgewise Therapeutics
Jun 1, 2026
Reiterated: Buy
Price Target: $46 → $66
Current: $40.83
Upside: +61.65%
Equillium
May 28, 2026
Maintained: Buy
Price Target: $6 → $7
Current: $2.62
Upside: +167.18%
Tectonic Therapeutic
May 26, 2026
Maintained: Buy
Price Target: $76 → $81
Current: $32.50
Upside: +149.23%
BridgeBio Pharma
May 26, 2026
Downgraded: Hold
Price Target: n/a
Current: $82.66
Upside: -
Spyre Therapeutics
Apr 10, 2026
Initiated Coverage: Buy
Price Target: $80
Current: $102.07
Upside: -21.62%
Scholar Rock Holding
Mar 30, 2026
Reiterated: Buy
Price Target: $53 → $60
Current: $54.04
Upside: +11.03%
Maze Therapeutics
Mar 25, 2026
Reiterated: Buy
Price Target: $48 → $56
Current: $29.39
Upside: +90.54%
Jan 26, 2026
Reiterated: Buy
Price Target: $40
Current: $12.45
Upside: +221.29%
Jan 13, 2026
Reiterated: Buy
Price Target: $21 → $26
Current: $5.91
Upside: +339.93%
Jan 13, 2026
Reiterated: Buy
Price Target: $108 → $117
Current: $76.02
Upside: +53.91%
Dec 11, 2025
Initiated Coverage: Buy
Price Target: $28
Current: $11.05
Upside: +153.39%
Oct 17, 2025
Initiated Coverage: Buy
Price Target: $271
Current: $268.57
Upside: +0.90%
Aug 25, 2025
Maintained: Buy
Price Target: $31 → $35
Current: $23.99
Upside: +45.89%
Jul 30, 2025
Downgraded: Hold
Price Target: n/a
Current: $82.62
Upside: -
Nov 16, 2021
Maintained: Buy
Price Target: $26 → $6
Current: $45.44
Upside: n/a
Oct 28, 2021
Maintained: Buy
Price Target: $102 → $100
Current: $58.95
Upside: n/a
Mar 22, 2021
Initiated Coverage: Buy
Price Target: $26
Current: $3.56
Upside: n/a
Mar 16, 2021
Maintained: Hold
Price Target: $7 → $8
Current: $9.62
Upside: n/a
Mar 16, 2021
Maintained: Buy
Price Target: $29 → $12
Current: $30.95
Upside: n/a
Mar 10, 2021
Maintained: Buy
Price Target: $49 → $58
Current: $29.91
Upside: n/a
Mar 2, 2021
Maintained: Hold
Price Target: $156 → $72
Current: $17.61
Upside: n/a
Feb 22, 2021
Maintained: Buy
Price Target: $169 → $196
Current: $531.79
Upside: n/a
Feb 11, 2021
Maintained: Buy
Price Target: $62 → $98
Current: $2.03
Upside: n/a
Jan 25, 2021
Maintained: Hold
Price Target: $64 → $99
Current: $31.71
Upside: n/a
Jan 19, 2021
Reiterated: Buy
Price Target: $50 → $60
Current: $109.81
Upside: n/a
Jan 11, 2021
Maintained: Hold
Price Target: $53 → $54
Current: $78.84
Upside: n/a
Nov 20, 2020
Maintained: Buy
Price Target: $76 → $78
Current: $41.00
Upside: n/a
Nov 6, 2020
Maintained: Hold
Price Target: $11 → $12
Current: $4.00
Upside: n/a
Nov 5, 2020
Maintained: Hold
Price Target: $21 → $24
Current: $13.04
Upside: n/a
Oct 8, 2020
Maintained: Buy
Price Target: $27 → $43
Current: $11.33
Upside: n/a
Sep 23, 2020
Reiterated: Buy
Price Target: n/a
Current: $529.00
Upside: n/a
Sep 15, 2020
Maintained: Sell
Price Target: $14
Current: $18.58
Upside: n/a
Aug 3, 2020
Maintained: Hold
Price Target: $5
Current: $3.71
Upside: n/a
Jul 7, 2020
Maintained: Hold
Price Target: $16
Current: $55.82
Upside: n/a
Nov 7, 2019
Downgraded: Hold
Price Target: $16 → $4
Current: $0.0001
Upside: n/a
Jan 18, 2018
Initiated Coverage: Buy
Price Target: $17
Current: $0.746
Upside: n/a